REVXF (Revenio Group Oyj) Other Stockholders Equity: $59.7 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

REVXF Revenio Group Oyj REVXF
82 GF Score
Price $16.41
GF Value $40.89
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Revenio Group Oyj Other Stockholders Equity?

Revenio Group Oyj REVXF 82 Other Stockholders Equity is $59.7 Mil as of Mar. 2026. GuruFocus rates REVXF with a GF Score™ of 82/100 and a GF Value™ of $40.89 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Revenio Group Oyj's Other Stockholders Equity for the quarter that ended in Mar. 2026 was $59.7 Mil.

Revenio Group Oyj's quarterly Other Stockholders Equity declined from Sep. 2025 ($60.4 Mil) to Dec. 2025 ($60.4 Mil) and declined from Dec. 2025 ($60.4 Mil) to Mar. 2026 ($59.7 Mil).

Revenio Group Oyj's annual Other Stockholders Equity declined from Dec. 2023 ($57.6 Mil) to Dec. 2024 ($54.3 Mil) but then increased from Dec. 2024 ($54.3 Mil) to Dec. 2025 ($60.4 Mil).

Revenio Group Oyj Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Revenio Group Oyj's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Revenio Group Oyj Other Stockholders Equity Chart

Revenio Group Oyj Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 60.04 56.38 57.59 54.31 60.43

Revenio Group Oyj Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 56.11 59.52 60.45 60.43 59.65
REVXF
82GF Score
Revenio Group Oyj REVXF
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Revenio Group Oyj Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $59.7 Mil mean?
Revenio Group Oyj (REVXF) has a Other Stockholders Equity of $59.7 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Revenio Group Oyj and its competitors.
Is Revenio Group Oyj's Other Stockholders Equity too high?
Revenio Group Oyj's current Other Stockholders Equity is $59.7 Mil. Overall, Revenio Group Oyj has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Revenio Group Oyj's Other Stockholders Equity compare to ABT and SYK?
Revenio Group Oyj's Other Stockholders Equity of $59.7 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Revenio Group Oyj and its competitors. Revenio Group Oyj's current Other Stockholders Equity is $59.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revenio Group Oyj stock overvalued right now?
Based on GuruFocus' analysis, Revenio Group Oyj (REVXF) is currently considered Significantly Undervalued. The stock's GF Value™ is $40.89, compared to a current price of $16.41 — trading 59.9% below its estimated fair value. The current Other Stockholders Equity is $59.7 Mil. Revenio Group Oyj's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Revenio Group Oyj (REVXF), the current Other Stockholders Equity is $59.7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Revenio Group Oyj (REVXF) Overvalued in 2026?

Based on GuruFocus' analysis, Revenio Group Oyj stock appears to be undervalued. The current stock price of $16.41 is trading 59.9% below its estimated GF Value™ of $40.89. GuruFocus considers Revenio Group Oyj to be Significantly Undervalued.

Key valuation signals for REVXF:

  • Other Stockholders Equity: $59.7 Mil
  • GF Value™: $40.89 vs. price of $16.41 (59.9% below fair value)
  • GF Score™: 82/100 with 2 warning signs

No single metric tells the full story. See the REVXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Revenio Group Oyj Business Description

Address Harkahaankuja 7, Vantaa, FIN, 01730
Revenio Group Oyj is a Finnish health technology company. It develops and commercializes effective, easy-to-use health tech-related screening devices for detecting diseases of public health significance. Its ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), and perimeter and fundus imaging devices under the iCare brand. Its eye care software platform, Oculo, offers clinical communication, telehealth, remote patient monitoring, and data analytics capabilities. The company generates the majority of its revenue from the United States.
82GF Score

Get the complete analysis for REVXF

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.41
Price
$40.89
GF Value